Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001737287-23-000004

EVP of R&D acquired 251,908 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Roberts Zachary · EVP of R&D

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-20 Grant or award : show line 1 in the form +251,908 251,908 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-20 Grant or award : show line 2 in the form Stock Option (Right to Buy) +873,015 873,015 D
Loading xslF345X03/primary_doc.xml…